FindTrial
Sign In

Tubulointerstitiaalinefriitti - Riskitekijöiden kartoitus ja lääkehoidon vaikutus sairauden kulkuun. - TIN

Tubulointerstitiaalinefriitti - Riskitekijöiden kartoitus ja lääkehoidon vaikutus sairauden kulkuun. - TIN

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2007-005956-18-FI
Enrollment
Unknown
Registered
2007-11-30
Start date
2008-01-18
Completion date
Unknown
Last updated
2012-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tubulointerstitiaalinefriittiä sairastavat lapset MedDRA version: 9.1 Level: LLT Classification code 10048302 Term: Tubulointerstitial nephritis

Interventions

Trade Name: Prednisolon Pharmaceutical Form: INN or Proposed INN: PREDNISOLONE CAS Number: 50248 Pharmaceutical form of the placebo: Tablet Route of administration of the placebo: Oral use

Sponsors

Timo Jahnukainen
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? yes Number of subjects for this age range: F.1.2 Adults (18-64 years) no F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Main Objective: ;Secondary Objective: ;Primary end point(s):—

Countries

Finland

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026